A fter years of work, scientists have solved the mystery of an unusual side effect that impacted some recipients of the Oxford/AstraZeneca and Johnson & Johnson COVID-19 vaccines. Most importantly, ...

The University of Oxford last month launched the world’s first phase II clinical trial of a Nipah virus vaccine candidate. The trial, which enrolled 306 healthy participants aged 18 to 55, was ...

Discovery caps 5-year journey to get to the bottom of one of the most puzzling chapters of the COVID-19 pandemic ...

A Nipah virus vaccine developed by the University of Tokyo is set to begin Phase 1 human trials in April, offering hope ...

Researchers at the University of Oxford report that a routine shingles shot may do more than prevent a painful rash. Their work, supported by the National Institute for Health and other funders, ...

Besides protecting against the disease, the shingles vaccine could also be linked to slower biological ageing, a new study ...

The Food and Drug Administration has refused to review an application from the biotech company Moderna to approve its ...

Human challenge trials offer a complementary approach. By safely and deliberately exposing healthy adult volunteers to a well characterised virus under controlled conditions, researchers can generate ...

Researchers pinpoint the precise genetic & molecular mechanism behind rare COVID vaccine blood clots (VITT), revealing how immune system errors trigger dangerous clotting. Learn more.

Scientists say they have identified a mutated autoantibody gene as the mechanism behind rare but serious abnormal blood ...

The roadmap was developed under the leadership of the West African Health Organisation (WAHO), with support from the Coalition for Epidemic Preparedness Innovations (CEPI), as part of efforts to ...

Getty ImagesNew research led by Flinders University and international experts has finally uncovered how a rare blood clotting ...